Researchers suggest that the administration of intravenous immunoglobulin (IVIG) may not be necessary in women with low-risk FNAIT pregnancies. Fetal and neonatal alloimmune thrombocytopenia (FNAIT), ...

Fintel reports that on January 13, 2025, JP Morgan upgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from ...

Patients with a low delta IgG had a more severe course of the disease, including slower recovery and a decreased chance of being able to walk unaided at 6 months (p < .001). Of the 27 patients who ...

Royal Bank of Canada lowered shares of IGM Biosciences (NASDAQ:IGMS – Free Report) from an outperform rating to a sector ...

IGM Biosciences (NASDAQ:IGMS – Get Free Report) had its target price reduced by research analysts at Truist Financial from ...

Staff cuts could leave IGM Biosciences with fewer than 55 employees. The company is also halting development of two ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on IGM Biosciences (IGMS – Research Report) and ...

The British study looked at two groups of pregnant mares and their subsequent foals -- one getting a grain mix, and one who ...

IGM Biosciences (IGMS – Research Report) received a Hold rating and a $2.00 price target from Jefferies analyst Roger Song today. The company’s ...

Spirulina-derived EVs (SPEVs) also trigger pro-inflammatory responses to innate immune cells without inducing toxicity in ...

The prognostic values of BMI in patients with NMOSD-AQP4 were also tested using univariable and multivariable Cox proportional hazards regression with Firth’s penalised likelihood bias-reduction ...